60 day FRN

8259

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Cities .................................................
Cities .................................................

Annual ..............................................
One-time Addition of Diseases and
Data Elements.

2
2

1
1

75
1

150
2

Total ...........................................

...........................................................

........................

........................

........................

18,294

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03078 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–2022–1050; Docket No. CDC–2022–
0025]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled CDC/ATSDR Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery.
The information collection activities
provide a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the federal
government’s commitment to improving
service delivery.
DATES: CDC must receive written
comments on or before April 15, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0025 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
SUMMARY:

jspears on DSK121TN23PROD with NOTICES1

Number of
responses per
respondent

Number of
respondents

Type of respondent

VerDate Sep<11>2014

17:54 Feb 11, 2022

Jkt 256001

• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,

PO 00000

Frm 00033

Fmt 4703

Sfmt 4703

including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
CDC/ATSDR Generic Clearance for
the Collection of Qualitative Feedback
on Agency Service Delivery (OMB
Control No. 0920–1050, Exp. 5/31/
2022)—Extension—Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The information collection activities
associated with this Generic clearance
provide a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the federal
government’s commitment to improving
service delivery. By qualitative
feedback, information will be collected
that provides useful insights on
perceptions and opinions, but are not
statistical surveys that yield quantitative
results that can be generalized to the
population of study.
Feedback from respondents will
provide insights into customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between
CDC and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
The solicitation of feedback will target
areas such as: Timeliness,

E:\FR\FM\14FEN1.SGM

14FEN1

8260

Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices

appropriateness, accuracy of
information, courtesy, efficiency of
service delivery, and resolution of
issues with service delivery. Responses
will be assessed to plan and inform
efforts to improve or maintain the
quality of service offered to the public.
If this information is not collected, vital
feedback from customers and
stakeholders on CDC’s services will be
unavailable.
CDC will only submit an individual
collection for approval under this
Generic clearance mechanism if it meets
the following conditions:
• The collection is voluntary;
• The collection is low-burden for
respondents (based on considerations of
total burden hours, total number of
respondents, or burden-hours per
respondent) and are low-cost for both
the respondents and the federal
government;
• The collection is non-controversial
and does not raise issues of concern to
other federal agencies;
• The collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future;
• Personally identifiable information
(PII) is collected only to the extent
necessary and is not retained;

• Information gathered is intended to
be used only internally for general
service improvement and program
management purposes and is not
intended for release outside of the
agency (if released, the agency must
indicate the qualitative nature of the
information);
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions;
and
• Information gathered will yield
qualitative information (the collection
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study).
Feedback collected under this CDC
Generic clearance provides useful
information, but it does not yield data
that can be generalized to the overall
population. This type of Generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: The
target population to which
generalizations will be made, the

sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other Generic
mechanisms that are designed to yield
quantitative results.
As a general matter, individual
information collections will not result
in any new system of records containing
privacy information and will not ask
questions of a sensitive nature, such as
sexual behavior and attitudes, religious
beliefs, and other matters that are
commonly considered private.
Based on the number of burden hours
used during the previous approval
period and the number of respondents
involved in this and other expiring
collections, CDC requests OMB approval
for an estimated 22,250 annual burden
hours. There are no costs to respondents
other than their time to participate.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Individuals and Households, Businesses and Organizations, State,
Local or Tribal Government.

In-person surveys, Online surveys,
Telephone surveys, In-person observation/testing, Interviews.
Focus groups ...................................
Customer comment cards, Interactive Voice surveys.
...........................................................

Total ...........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03079 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P

jspears on DSK121TN23PROD with NOTICES1

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
ACTION:

Notice.

VerDate Sep<11>2014

17:54 Feb 11, 2022

Jkt 256001

Number of
responses per
respondent

Average hours
per response

Total response
burden
(hours)

10,000

1

30/60

5,000

1,000
61,000

1
1

2
15/60

2,000
15,250

........................

........................

........................

22,250

Number of
respondents

Type of respondent

The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
Advisory Council for the Elimination of
Tuberculosis (ACET). The ACET
consists of 10 experts including the
Chair in fields associated with public
health, epidemiology, immunology,
infectious disease, pulmonary disease,
pediatrics, tuberculosis, microbiology,
and preventive health care delivery.
ACET provides advice and
recommendations regarding the
elimination of tuberculosis (TB) to the
Secretary, HHS; the Assistant Secretary
for Health, HHS; and the CDC Director.
ACET (a) makes recommendations on
policies, strategies, objectives, and
priorities; (b) addresses development

SUMMARY:

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

and application of new technologies; (c)
provides guidance and review of CDC’s
TB prevention research portfolio and
program priorities; and (d) reviews the
extent to which progress has been made
toward eliminating TB.
DATES: Nominations for membership on
the ACET must be received no later than
May 31, 2022. Packages received after
this time will not be considered for the
current membership cycle.
ADDRESSES: All nominations should be
mailed to CDC, 1600 Clifton Road NE,
Mailstop US8–6, Atlanta, Georgia
30329–4027; or emailed (recommended)
to nchhstppolicy@cdc.gov; or faxed to
(404) 639–8600.
FOR FURTHER INFORMATION CONTACT:
Marah Condit, MS, Committee

E:\FR\FM\14FEN1.SGM

14FEN1